Yao De-sheng, Li Li, Garson Kenneth, Vanderhyden Barbara C
Department of Gynecological Oncology, Affiliated Cancer Hospital, Guangxi Medical University, Nanning 530021, China.
Zhonghua Fu Chan Ke Za Zhi. 2006 May;41(5):333-8.
To study the inhibition of OPCML on ovarian cancer cell lines using a lentiviral vector system for efficient gene transduction.
The murine OPCML cDNA was amplified by PCR from CD1 murine brain cDNA using gene specific primers, and subcloned into the lentiviral vector, pWPI-GFP, to generate the lentiviral expression vector, pWPI-OPCML. Recombinant lentiviruses were produced by 293T cells following the co-transfection of pWPI-OPCML, with the packaging plasmids pCMV-dR8.74 and pMDG. The resulting recombinant lentiviruses which carried OPCML or control viruses (only carrying GFP), were then used to infect the human ovarian cancer cell lines A2780 and OCC1 in addition to normal CD1 mouse ovarian surface epithelial cells. The infected cells were then characterized by cell proliferation assays, cell aggregation assays, cell cycle analysis by flow cytometry and tumorigenicity assays following injection into nude mice.
(1) The efficiency of infection of the cell lines using the lentiviral vectors was almost 100% allowing the stable expression of OPCML in nearly all cells. Stable expression of OPCML (60 000) and GFP (27 000) proteins was confirmed by western blot analysis. (2) A2780 cells expressing OPCML [(7.6 +/- 1.0) x 10(5)] grew slowly compared to A2780 parental [(20.0 +/- 2.6) x 10(5)] or control virus infected cells [(18.1 +/- 1.7) x 10(5), P < 0.01], but the expression of OPCML had no effect on the proliferation rates of OCC1 and the normal CD1 cells when compared to their respective parental or controls (P > 0.05). (3) Flow cytometry based cell cycle assays showed that the expression of OPCML could arrest A2780 cells (G(0) approximately G(1) 67% vs 75%, P < 0.05); but not OCC1, CD1 cells. (4) The rate of aggregation of single cell suspensions was measured and found to be increased in all cell lines expressing OPCML indicating the increased cell surface adhesion mediated by OPCML. (5) A2780 cells expressing OPCML only formed a single tumor in 1/4 mice (10 mg) which was significantly smaller than controls [4/4; A2780 (280 +/- 53) mg and A2780/pWPI (677 +/- 323) mg; P < 0.01]. Expression of OPCML in tumor was confirmed by immunohistochemistry.
The use of lentiviral vectors allowed the efficient expression of OPCML in nearly 100% of target cells. Expression of the OPCML cDNA resulted in an increase of cell adhesion in all cell lines tested, and decreased the proliferation and tumorigenicity of the A2780 ovarian cancer cell line. This indicates that the OPCML may be a new tumor suppressor gene.
利用慢病毒载体系统进行高效基因转导,研究OPCML对卵巢癌细胞系的抑制作用。
使用基因特异性引物通过PCR从CD1小鼠脑cDNA中扩增小鼠OPCML cDNA,并亚克隆到慢病毒载体pWPI - GFP中,构建慢病毒表达载体pWPI - OPCML。将pWPI - OPCML与包装质粒pCMV - dR8.74和pMDG共转染293T细胞,产生重组慢病毒。所得携带OPCML的重组慢病毒或对照病毒(仅携带GFP)用于感染人卵巢癌细胞系A2780和OCC1以及正常CD1小鼠卵巢表面上皮细胞。然后通过细胞增殖试验、细胞聚集试验、流式细胞术细胞周期分析以及注射到裸鼠体内后的致瘤性试验对感染细胞进行表征。
(1)使用慢病毒载体对细胞系的感染效率几乎为100%,使得OPCML在几乎所有细胞中稳定表达。通过蛋白质印迹分析证实了OPCML(60 000)和GFP(27 000)蛋白的稳定表达。(2)与A2780亲本细胞[(20.0±2.6)×10⁵]或对照病毒感染细胞[(18.1±1.7)×10⁵,P<0.01]相比,表达OPCML的A2780细胞[(7.6±1.0)×10⁵]生长缓慢,但与各自的亲本或对照相比,OPCML的表达对OCC1和正常CD1细胞的增殖率没有影响(P>0.05)。(3)基于流式细胞术的细胞周期分析表明,OPCML的表达可使A2780细胞停滞(G₀期至G₁期从75%降至67%,P<0.05);但对OCC1和CD1细胞无此作用。(4)测量单细胞悬液的聚集率,发现所有表达OPCML的细胞系中聚集率均增加,表明OPCML介导细胞表面黏附增加。(5)表达OPCML的A2780细胞在1/4的小鼠(10 mg)中仅形成一个肿瘤,明显小于对照组[4/4;A2780(280±53)mg和A2780/pWPI(677±323)mg;P<0.01]。通过免疫组织化学证实肿瘤中OPCML的表达。
使用慢病毒载体可使OPCML在近100%的靶细胞中高效表达。OPCML cDNA的表达导致所有测试细胞系中细胞黏附增加,并降低了A2780卵巢癌细胞系的增殖和致瘤性。这表明OPCML可能是一种新的肿瘤抑制基因。